MicroRNAs: Potential mediators and biomarkers of diabetic complications

Free Radical Biology and Medicine

Volumn 64, Issue , 2013, Pages 85-94

  Kato, Mitsuo ^a   Castro, Nancy E ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Diabetic complications; Free radicals; MicroRNA

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; DICER; GROWTH FACTOR; MICRORNA; MICRORNA 1; MICRORNA 132; MICRORNA 133; MICRORNA 146; MICRORNA 146A; MICRORNA 155; MICRORNA 192; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 206; MICRORNA 21; MICRORNA 216A; MICRORNA 217; MICRORNA 29; MICRORNA 29B; MICRORNA 34A; MICRORNA 93; MICRORNA 96; PROTEIN KINASE B; PROTEIN P53; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BIOGENESIS; BIOINFORMATICS; CAENORHABDITIS ELEGANS; CELL STRESS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; UPREGULATION;

DIABETIC COMPLICATIONS; FREE RADICALS; MICRORNA;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84885183542     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.06.009     Document Type: Review

References (153)

1. He, Z.; King, G. L. Microvascular complications of diabetes. Endocrinol. Metab. Clin. North Am. 33:215-238; 2004. xi-xii. (Pubitemid 38438432)
2. Beckman, J. A.; Creager, M. A.; Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581; 2002. (Pubitemid 34517204)
3. Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412; 1991.
4. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820; 2001. (Pubitemid 34000785)
5. Clempus, R. E.; Griendling, K. K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 71:216-225; 2006.
6. Kim, W.; Hudson, B. I.; Moser, B.; Guo, J.; Rong, L. L.; Lu, Y.; Qu, W.; Lalla, E.; Lerner, S.; Chen, Y.; Yan, S. S.; D'Agati, V.; Naka, Y.; Ramasamy, R.; Herold, K.; Yan, S. F.; Schmidt, A. M. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. Ann. N. Y. Acad. Sci. 1043:553-561; 2005. (Pubitemid 41123945)
7. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321; 1988.
8. Ishii, H.; Koya, D.; King, G. L. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J. Mol. Med. 76:21-31; 1998. (Pubitemid 28085058)
9. Das Evcimen, N.; King, G. L. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res 55:498-510; 2007. (Pubitemid 46962309)
10. Devaraj, S.; Dasu, M. R.; Jialal, I. Diabetes is a proinflammatory state: a translational perspective. Expert Rev. Endocrinol. Metab. 5:19-28; 2010.
11. Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625; 2005. (Pubitemid 40770750)
12. Zou, M. H.; Cohen, R.; Ullrich, V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97; 2004. (Pubitemid 39207182)
13. Devaraj, S.; Glaser, N.; Griffen, S.; Wang-Polagruto, J.; Miguelino, E.; Jialal, I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55:774-779; 2006. (Pubitemid 43343235)
14. Schmidt, A. M.; Hori, O.; Brett, J.; Yan, S. D.; Wautier, J. L.; Stern, D. Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14:1521-1528; 1994.
15. Shanmugam, N.; Gaw Gonzalo, I. T.; Natarajan, R. Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53:795-802; 2004. (Pubitemid 38270651)
16. Cnop, M.; Foufelle, F.; Velloso, L. A. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18:59-68; 2012.
17. Lowell, B. B.; Shulman, G. I. Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387; 2005. (Pubitemid 40139974)
18. Vaziri, N. D. Protective effect of nrf2 and catalase in maternal diabetes-induced perinatal hypertension and kidney disease. Diabetes 61:2400-2402; 2012.
19. Kaspar, J. W.; Niture, S. K.; Jaiswal, A. K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47:1304-1309; 2009.
20. Babelova, A.; Avaniadi, D.; Jung, O.; Fork, C.; Beckmann, J.; Kosowski, J.; Weissmann, N.; Anilkumar, N.; Shah, A. M.; Schaefer, L.; Schroder, K.; Brandes, R. P. Role of Nox4 in murine models of kidney disease. Free Radic. Biol. Med. 53:842-853; 2012.
21. Zhu, Y.; Usui, H. K.; Sharma, K. Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin. Nephrol. 27:153-160; 2007. (Pubitemid 46553714)
22. King, G. L. The role of inflammatory cytokines in diabetes and its complications. J. Periodontol. 79:1527-1534; 2008.
23. Villeneuve, L. M.; Reddy, M. A.; Natarajan, R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin. Exp. Pharmacol. Physiol. 38:401-409; 2011.
24. Cooper, M. E.; El-Osta, A. Epigenetics: mechanisms and implications for diabetic complications. Circ. Res. 107:1403-1413; 2010.
25. Ambros, V. The functions of animal microRNAs. Nature 431:350-355; 2004. (Pubitemid 39265675)
26. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297; 2004.
27. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233; 2009.
28. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714; 2009.
29. He, L.; Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522-531; 2004. (Pubitemid 38868508)
30. Zamore, P. D.; Haley, B. Ribo-gnome: the big world of small RNAs. Science 309:1519-1524; 2005. (Pubitemid 41266468)
31. Filipowicz, W.; Bhattacharyya, S. N.; Sonenberg, N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9:102-114; 2008.
32. Stefani, G.; Slack, F. J. Small non-coding RNAs in animal development. Nat. Rev 9:219-230; 2008. (Pubitemid 351301826)
33. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854; 1993.
34. Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-862; 1993. (Pubitemid 24014543)
35. Kim, V. N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev 6:376-385; 2005. (Pubitemid 40637855)
36. Davis, B. N.; Hilyard, A. C.; Nguyen, P. H.; Lagna, G.; Hata, A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 39:373-384; 2010.
37. Davis, B. N.; Hilyard, A. C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61; 2008. (Pubitemid 351931982)
38. Suzuki, H. I.; Yamagata, K.; Sugimoto, K.; Iwamoto, T.; Kato, S.; Miyazono, K. Modulation of microRNA processing by p53. Nature 460:529-533; 2009.
39. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell 120:635-647; 2005. (Pubitemid 40343076)
40. Sampson, V. B.; Rong, N. H.; Han, J.; Yang, Q.; Aris, V.; Soteropoulos, P.; Petrelli, N. J.; Dunn, S. P.; Krueger, L. J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67:9762-9770; 2007. (Pubitemid 47621223)
41. Mayr, C.; Hemann, M. T.; Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576-1579; 2007. (Pubitemid 46449474)
42. Hagan, J. P.; Piskounova, E.; Gregory, R. I. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 16:1021-1025; 2009.
43. Heo, I.; Joo, C.; Cho, J.; Ha, M.; Han, J.; Kim, V. N. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 32:276-284; 2008.
44. Piskounova, E.; Polytarchou, C.; Thornton, J. E.; LaPierre, R. J.; Pothoulakis, C.; Hagan, J. P.; Iliopoulos, D.; Gregory, R. I. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147:1066-1079; 2011.
45. Ruvkun, G. The perfect storm of tiny RNAs. Nat. Med 14:1041-1045; 2008.
46. Cheloufi, S.; Dos Santos, C. O.; Chong, M. M.; Hannon, G. J. A dicerindependent miRNA biogenesis pathway that requires Ago catalysis. Nature 465:584-589; 2010.
47. Ota, H.; Sakurai, M.; Gupta, R.; Valente, L.; Wulff, B. E.; Ariyoshi, K.; Iizasa, H.; Davuluri, R. V.; Nishikura, K. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153:575-589; 2013.
48. Suzuki, H. I.; Arase, M.; Matsuyama, H.; Choi, Y. L.; Ueno, T.; Mano, H.; Sugimoto, K.; Miyazono, K. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44:424-436; 2011.
49. Xhemalce, B.; Robson, S. C.; Kouzarides, T. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 151:278-288; 2012.
50. Upton, J. P.; Wang, L.; Han, D.; Wang, E. S.; Huskey, N. E.; Lim, L.; Truitt, M.; McManus, M. T.; Ruggero, D.; Goga, A.; Papa, F. R.; Oakes, S. A. IRE1alpha cleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2. Science 338:818-822; 2012.
51. Gibbings, D.; Mostowy, S.; Jay, F.; Schwab, Y.; Cossart, P.; Voinnet, O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat. Cell Biol. 14:1314-1321; 2012.
52. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B. Prediction of mammalian microRNA targets. Cell 115: 787-798; 2003. (Pubitemid 38058492)
53. Mourelatos, Z. Small RNAs: the seeds of silence. Nature 455:44-45; 2008.
54. Ha, I.; Wightman, B.; Ruvkun, G. A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev 10:3041-3050; 1996. (Pubitemid 26412530)
55. Vella, M. C.; Choi, E. Y.; Lin, S. Y.; Reinert, K.; Slack, F. J. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3′UTR. Genes Dev. 18: 132-137; 2004.
56. Tay, Y.; Zhang, J.; Thomson, A. M.; Lim, B.; Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455:1124-1128; 2008.
57. Didiano, D.; Hobert, O. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol. 13:849-851; 2006. (Pubitemid 44338780)
58. Chi, S. W.; Hannon, G. J.; Darnell, R. B. An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 19:321-327; 2012.
59. Chi, S. W.; Zang, J. B.; Mele, A.; Darnell, R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486; 2009.
60. Harvey, S. J.; Jarad, G.; Cunningham, J.; Goldberg, S.; Schermer, B.; Harfe, B. D.; McManus, M. T.; Benzing, T.; Miner, J. H. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J. Am. Soc. Nephrol. 19:2150-2158; 2008.
61. Ho, J.; Ng, K. H.; Rosen, S.; Dostal, A.; Gregory, R. I.; Kreidberg, J. A. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J. Am. Soc. Nephrol. 19:2069-2075; 2008.
62. Ho, J.; Pandey, P.; Schatton, T.; Sims-Lucas, S.; Khalid, M.; Frank, M. H.; Hartwig, S.; Kreidberg, J. A. The pro-apoptotic protein Bim is a microRNA target in kidney progenitors. J. Am. Soc. Nephrol. 22:1053-1063; 2011.
63. Shi, S.; Yu, L.; Chiu, C.; Sun, Y.; Chen, J.; Khitrov, G.; Merkenschlager, M.; Holzman, L. B.; Zhang, W.; Mundel, P.; Bottinger, E. P. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J. Am. Soc. Nephrol. 19:2159-2169; 2008.
64. Nagalakshmi, V. K.; Ren, Q.; Pugh, M. M.; Valerius, M. T.; McMahon, A. P.; Yu, J. Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney. Kidney Int. 79:317-330; 2011.
65. Zhdanova, O.; Srivastava, S.; Di, L.; Li, Z.; Tchelebi, L.; Dworkin, S.; Johnstone, D. B.; Zavadil, J.; Chong, M. M.; Littman, D. R.; Holzman, L. B.; Barisoni, L.; Skolnik, E. Y. The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy. Kidney Int. 80:719-730; 2011.
66. Zhao, Y.; Ransom, J. F.; Li, A.; Vedantham, V.; von Drehle, M.; Muth, A. N.; Tsuchihashi, T.; McManus, M. T.; Schwartz, R. J.; Srivastava, D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317; 2007. (Pubitemid 46574975)
67. Chen, J. F.; Murchison, E. P.; Tang, R.; Callis, T. E.; Tatsuguchi, M.; Deng, Z.; Rojas, M.; Hammond, S. M.; Schneider, M. D.; Selzman, C. H.; Meissner, G.; Patterson, C.; Hannon, G. J.; Wang, D. Z. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 105:2111-2116; 2008. (Pubitemid 351439473)
68. Kato, M.; Park, J. T.; Natarajan, R. MicroRNAs and the glomerulus. Exp. Cell Res. 318:993-1000; 2012.
69. Ziyadeh, F. N.; Sharma, K. Overview: combating diabetic nephropathy. J. Am. Soc. Nephrol. 14:1355-1357; 2003. (Pubitemid 36514676)
70. Kato, M.; Zhang, J.; Wang, M.; Lanting, L.; Yuan, H.; Rossi, J. J.; Natarajan, R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. USA 104:3432-3437; 2007. (Pubitemid 46364176)
71. Sharma, K.; Ziyadeh, F. N. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146; 1995.
72. Yamamoto, T.; Nakamura, T.; Noble, N. A.; Ruoslahti, E.; Border, W. A. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90:1814-1818; 1993. (Pubitemid 23069947)
73. Kato, M.; Wang, L.; Putta, S.; Wang, M.; Yuan, H.; Sun, G.; Lanting, L.; Todorov, I.; Rossi, J. J.; Natarajan, R. Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells. J. Biol. Chem. 285:34004-34015; 2010.
74. Kato, M.; Arce, L.; Wang, M.; Putta, S.; Lanting, L.; Natarajan, R. A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int. 80:358-368; 2011.
75. Kato, M.; Putta, S.; Wang, M.; Yuan, H.; Lanting, L.; Nair, I.; Gunn, A.; Nakagawa, Y.; Shimano, H.; Todorov, I.; Rossi, J. J.; Natarajan, R. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11: 881-889; 2009.
76. Deshpande, S. D.; Putta, S.; Wang, M.; Lai, J. Y.; Bitzer, M.; Nelson, R. G.; Lanting, L. L.; Kato, M.; Natarajan, R. Transforming growth factor-β induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes; 2013. in press, May 6, 2013, http://dx.doi.org/10.2337/ db13-0305.
77. Kato, M.; Natarajan, R. MicroRNA circuits in transforming growth factor-beta actions and diabetic nephropathy. Semin. Nephrol. 32:253-260; 2012.
78. Chung, A. C.; Huang, X. R.; Meng, X.; Lan, H. Y. miR-192 mediates TGF-beta/ Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21:1317-1325; 2010.
79. Kato, M.; Dang, V.; Wang, M.; Park, J. T.; Deshpande, S. D.; Kadam, S.; Mardiros, A.; Zhan, Y.; Oettgen, P.; Putta, S.; Yuan, H.; Lanting, L.; Natarajan, R. TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci. Signaling 6:ra43; 2013.
80. Wang, Q.; Wang, Y.; Minto, A. W.; Wang, J.; Shi, Q.; Li, X.; Quigg, R. J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22:4126-4135; 2008.
81. Wang, X. X.; Jiang, T.; Shen, Y.; Caldas, Y.; Miyazaki-Anzai, S.; Santamaria, H.; Urbanek, C.; Solis, N.; Scherzer, P.; Lewis, L.; Gonzalez, F. J.; Adorini, L.; Pruzanski, M.; Kopp, J. B.; Verlander, J. W.; Levi, M. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 59:2916-2927; 2010.
82. Long, J.; Wang, Y.; Wang, W.; Chang, B. H.; Danesh, F. R. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 285:23457-23465; 2010.
83. Long, J.; Wang, Y.; Wang, W.; Chang, B. H.; Danesh, F. R. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem 286:11837-11848; 2011.
84. Wang, B.; Komers, R.; Carew, R.; Winbanks, C. E.; Xu, B.; Herman-Edelstein, M.; Koh, P.; Thomas, M.; Jandeleit-Dahm, K.; Gregorevic, P.; Cooper, M. E.; Kantharidis, P. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 23:252-265; 2012.
85. Qin, W.; Chung, A. C.; Huang, X. R.; Meng, X. M.; Hui, D. S.; Yu, C. M.; Sung, J. J.; Lan, H. Y. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 22:1462-1474; 2011.
86. Sun, L.; Zhang, D.; Liu, F.; Xiang, X.; Ling, G.; Xiao, L.; Liu, Y.; Zhu, X.; Zhan, M.; Yang, Y.; Kondeti, V. K.; Kanwar, Y. S. Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J. Pathol. 225:364-377; 2011.
87. Mu, J.; Pang, Q.; Guo, Y. H.; Chen, J. G.; Zeng, W.; Huang, Y. J.; Zhang, J.; Feng, B. Functional implications of microRNA-215 in TGF-beta1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS One 8: e58622; 2013.
88. Krupa, A.; Jenkins, R.; Luo, D. D.; Lewis, A.; Phillips, A.; Fraser, D. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21:438-447; 2010.
89. Wang, B.; Herman-Edelstein, M.; Koh, P.; Burns, W.; Jandeleit-Dahm, K.; Watson, A.; Saleem, M.; Goodall, G. J.; Twigg, S. M.; Cooper, M. E.; Kantharidis, P. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59:1794-1802; 2010.
90. Wang, B.; Koh, P.; Winbanks, C.; Coughlan, M. T.; McClelland, A.; Watson, A.; Jandeleit-Dahm, K.; Burns, W. C.; Thomas, M. C.; Cooper, M. E.; Kantharidis, P. miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 60:280-287; 2011.
91. Dey, N.; Das, F.; Mariappan, M. M.; Mandal, C. C.; Ghosh-Choudhury, N.; Kasinath, B. S.; Choudhury, G. G. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J. Biol. Chem. 286:25586-25603; 2011.
92. Zhong, X.; Chung, A. C.; Chen, H. Y.; Dong, Y.; Meng, X. M.; Li, R.; Yang, W.; Hou, F. F.; Lan, H. Y. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56:663-674; 2013.
93. Zhang, Z.; Peng, H.; Chen, J.; Chen, X.; Han, F.; Xu, X.; He, X.; Yan, N. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 583:2009-2014; 2009.
94. Fu, Y.; Zhang, Y.; Wang, Z.; Wang, L.; Wei, X.; Zhang, B.; Wen, Z.; Fang, H.; Pang, Q.; Yi, F. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am. J. Nephrol. 32:581-589; 2010.
95. Natarajan, R.; Putta, S.; Kato, M. MicroRNAs and diabetic complications. J. Cardiovasc. Transl. Res. 5:413-422; 2012.
96. Kempen, J. H.; O'Colmain, B. J.; Leske, M. C.; Haffner, S. M.; Klein, R.; Moss, S. E.; Taylor, H. R.; Hamman, R. F. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol. 122:552-563; 2004. (Pubitemid 38456292)
97. Saaddine, J. B.; Honeycutt, A. A.; Narayan, K. M.; Zhang, X.; Klein, R.; Boyle, J. P. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch. Ophthalmol., 126; 1740-1747; 2008.
98. Kovacs, B.; Lumayag, S.; Cowan, C.; Xu, S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest. Ophthalmol. Visual Sci. 52:4402-4409; 2011.
99. Feng, B.; Chen, S.; McArthur, K.; Wu, Y.; Sen, S.; Ding, Q.; Feldman, R. D.; Chakrabarti, S. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 60:2975-2984; 2011.
100. McArthur, K.; Feng, B.; Wu, Y.; Chen, S.; Chakrabarti, S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 60:1314-1323; 2011.
101. Silva, V. A.; Polesskaya, A.; Sousa, T. A.; Correa, V. M.; Andre, N. D.; Reis, R. I.; Kettelhut, I. C.; Harel-Bellan, A.; De Lucca, F. L. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol. Vision 17: 2228-2240; 2011.
102. Natarajan, R.; Nadler, J. L. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24:1542-1548; 2004. (Pubitemid 39180875)
103. Libby, P.; Ridker, P. M.; Maseri, A. Inflammation and atherosclerosis. Circulation 105:1135-1143; 2002. (Pubitemid 34212626)
104. Shan, Z. X.; Lin, Q. X.; Deng, C. Y.; Zhu, J. N.; Mai, L. P.; Liu, J. L.; Fu, Y. H.; Liu, X. Y.; Li, Y. X.; Zhang, Y. Y.; Lin, S. G.; Yu, X. Y. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 584:3592-3600; 2010.
105. Katare, R.; Caporali, A.; Zentilin, L.; Avolio, E.; Sala-Newby, G.; Oikawa, A.; Cesselli, D.; Beltrami, A. P.; Giacca, M.; Emanueli, C.; Madeddu, P. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ. Res. 108:1238-1251; 2011.
106. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M. L.; Segnalini, P.; Gu, Y.; Dalton, N. D.; Elia, L.; Latronico, M. V.; Hoydal, M.; Autore, C.; Russo, M. A.; Dorn 2nd G. W.; Ellingsen, O.; Ruiz-Lozano, P.; Peterson, K. L.; Croce, C. M.; Peschle, C.; Condorelli, G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med 13:613-618; 2007. (Pubitemid 46828487)
107. Feng, B.; Chen, S.; George, B.; Feng, Q.; Chakrabarti, S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab. Res. Rev 26:40-49; 2010.
108. Horie, T.; Ono, K.; Nishi, H.; Iwanaga, Y.; Nagao, K.; Kinoshita, M.; Kuwabara, Y.; Takanabe, R.; Hasegawa, K.; Kita, T.; Kimura, T. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem. Biophys. Res. Commun. 389:315-320; 2009.
109. Lu, H.; Buchan, R. J.; Cook, S. A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 86:410-420; 2010.
110. Shen, E.; Diao, X.; Wang, X.; Chen, R.; Hu, B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am. J. Pathol. 179:639-650; 2011.
111. Greco, S.; Fasanaro, P.; Castelvecchio, S.; D'Alessandra, Y.; Arcelli, D.; Di Donato, M.; Malavazos, A.; Capogrossi, M. C.; Menicanti, L.; Martelli, F. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 61:1633-1641; 2012.
112. van Rooij, E.; Sutherland, L. B.; Liu, N.; Williams, A. H.; McAnally, J.; Gerard, R. D.; Richardson, J. A.; Olson, E. N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103:18255-18260; 2006. (Pubitemid 44871645)
113. Duisters, R. F.; Tijsen, A. J.; Schroen, B.; Leenders, J. J.; Lentink, V.; van der Made, I.; Herias, V.; van Leeuwen, R. E.; Schellings, M. W.; Barenbrug, P.; Maessen, J. G.; Heymans, S.; Pinto, Y. M.; Creemers, E. E. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104:170-178; 2009.
114. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M. A.; Licht, J. D.; Pena, J. T.; Rouhanifard, S. H.; Muckenthaler, M. U.; Tuschl, T.; Martin, G. R.; Bauersachs, J.; Engelhardt, S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984; 2008.
115. Reddy, M. A.; Natarajan, R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc. Res. 90:421-429; 2011.
116. Shanmugam, N.; Reddy, M. A.; Natarajan, R. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J. Biol. Chem 283:36221-36233; 2008.
117. Villeneuve, L. M.; Reddy, M. A.; Lanting, L. L.; Wang, M.; Meng, L.; Natarajan, R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. USA 105:9047-9052; 2008.
118. Villeneuve, L. M.; Kato, M.; Reddy, M. A.; Wang, M.; Lanting, L.; Natarajan, R. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 59:2904-2915; 2010.
119. Reddy, M. A.; Jin, W.; Villeneuve, L.; Wang, M.; Lanting, L.; Todorov, I.; Kato, M.; Natarajan, R. Pro-inflammatory role of microRNA-200 in vascular smooth muscle cells from diabetic mice. Arterioscler. Thromb. Vasc. Biol. 32:721-729; 2012.
120. Li, Y.; Song, Y. H.; Li, F.; Yang, T.; Lu, Y. W.; Geng, Y. J. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 381:81-83; 2009.
121. Wang, X. H.; Qian, R. Z.; Zhang, W.; Chen, S. F.; Jin, H. M.; Hu, R. M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 36:181-188; 2009.
122. Togliatto, G.; Trombetta, A.; Dentelli, P.; Rosso, A.; Brizzi, M. F. MIR221/ MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose-and AGE-mediated vascular cell damage. Diabetologia 54:1930-1940; 2011.
123. Caporali, A.; Meloni, M.; Vollenkle, C.; Bonci, D.; Sala-Newby, G. B.; Addis, R.; Spinetti, G.; Losa, S.; Masson, R.; Baker, A. H.; Agami, R.; le Sage, C.; Condorelli, G.; Madeddu, P.; Martelli, F.; Emanueli, C. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123:282-291; 2011.
124. Vasa-Nicotera, M.; Chen, H.; Tucci, P.; Yang, A. L.; Saintigny, G.; Menghini, R.; Mahe, C.; Agostini, M.; Knight, R. A.; Melino, G.; Federici, M. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis 217:326-330; 2011.
125. Muratsu-Ikeda, S.; Nangaku, M.; Ikeda, Y.; Tanaka, T.; Wada, T.; Inagi, R. Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. PLoS One 7:e41462; 2012.
126. Kato, M.; Yuan, H.; Xu, Z. G.; Lanting, L.; Li, S. L.; Wang, M.; Hu, M. C.; Reddy, M. A.; Natarajan, R. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 17: 3325-3335; 2006. (Pubitemid 44865275)
127. Beckman, J. D.; Chen, C.; Nguyen, J.; Thayanithy, V.; Subramanian, S.; Steer, C. J.; Vercellotti, G. M. Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J. Biol. Chem. 286:3194-3202; 2011.
128. Stachurska, A.; Ciesla, M.; Kozakowska, M.; Wolffram, S.; Boesch-Saadatmandi, C.; Rimbach, G.; Jozkowicz, A.; Dulak, J.; Loboda, A. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol. Nutr. Food Res. 57:504-515; 2013.
129. Chitnis, N. S.; Pytel, D.; Bobrovnikova-Marjon, E.; Pant, D.; Zheng, H.; Maas, N. L.; Frederick, B.; Kushner, J. A.; Chodosh, L. A.; Koumenis, C.; Fuchs, S. Y.; Diehl, J. A. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol. Cell 48:353-364; 2012.
130. Sangokoya, C.; Telen, M. J.; Chi, J. T. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 116: 4338-4348; 2010.
131. Yang, M.; Yao, Y.; Eades, G.; Zhang, Y.; Zhou, Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res. Treat. 129:983-991; 2011.
132. Eades, G.; Yang, M.; Yao, Y.; Zhang, Y.; Zhou, Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J. Biol. Chem. 286:40725-40733; 2011.
133. Mateescu, B.; Batista, L.; Cardon, M.; Gruosso, T.; de Feraudy, Y.; Mariani, O.; Nicolas, A.; Meyniel, J. P.; Cottu, P.; Sastre-Garau, X.; Mechta-Grigoriou, F. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat. Med 17: 1627-1635; 2011.
134. Roy, S.; Sen, C. K. miRNA in wound inflammation and angiogenesis. Microcirculation 19:224-232; 2012.
135. Shen, J.; Xia, W.; Khotskaya, Y. B.; Huo, L.; Nakanishi, K.; Lim, S. O.; Du, Y.; Wang, Y.; Chang, W. C.; Chen, C. H.; Hsu, J. L.; Wu, Y.; Lam, Y. C.; James, B. P.; Liu, X.; Liu, C. G.; Patel, D. J.; Hung, M. C. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497:383-387; 2013.
136. Farazi, T. A.; Spitzer, J. I.; Morozov, P.; Tuschl, T. miRNAs in human cancer. J. Pathol. 223:102-115; 2011.
137. Fabbri, M. miRNAs as molecular biomarkers of cancer. Expert Rev. Mol. Diagn. 10:435-444; 2010.
138. Wang, K.; Zhang, S.; Marzolf, B.; Troisch, P.; Brightman, A.; Hu, Z.; Hood, L. E.; Galas, D. J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. USA 106:4402-4407; 2009.
139. Mitchell, P. S.; Parkin, R. K.; Kroh, E. M.; Fritz, B. R.; Wyman, S. K.; Pogosova-Agadjanyan, E. L.; Peterson, A.; Noteboom, J.; O'Briant, K. C.; Allen, A.; Lin, D. W.; Urban, N.; Drescher, C. W.; Knudsen, B. S.; Stirewalt, D. L.; Gentleman, R.; Vessella, R. L.; Nelson, P. S.; Martin, D. B.; Tewari, M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105:10513-10518; 2008.
140. Tijsen, A. J.; Creemers, E. E.; Moerland, P. D.; de Windt, L. J.; van der Wal, A. C.; Kok, W. E.; Pinto, Y. M. MiR423-5p as a circulating biomarker for heart failure. Circ. Res. 106:1035-1039; 2010.
141. Szeto, C. C.; Ching-Ha, K. B.; Ka-Bik, L.; Mac-Moune, L. F.; Cheung-Lung, C. P.; Gang, W.; Kai-Ming, C.; Kam-Tao, L. P. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis. Mark 33:137-144; 2012.
142. Wang, G.; Kwan, B. C.; Lai, F. M.; Chow, K. M.; Kam-Tao, Li, P.; Szeto, C. C. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis. Mark 28:79-86; 2010.
143. Neal, C. S.; Michael, M. Z.; Pimlott, L. K.; Yong, T. Y.; Li, J. Y.; Gleadle, J. M. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol. Dial. Transplant. 26:3794-3802; 2011.
144. Luk, C. C.; Chow, K. M.; Kwok, J. S.; Kwan, B. C.; Chan, M. H.; Lai, K. B.; Lai, F. M.; Wang, G.; Li, P. K.; Szeto, C. C. Urinary biomarkers for the prediction of reversibility in acute-on-chronic renal failure. Dis. Mark 34:179-185; 2013.
145. Wang, G.; Kwan, B. C.; Lai, F. M.; Chow, K. M.; Li, P. K.; Szeto, C. C. Urinary sediment miRNA levels in adult nephrotic syndrome. Clin. Chim. Acta 418:5-11; 2013.
146. Yang, Y.; Xiao, L.; Li, J.; Kanwar, Y. S.; Liu, F.; Sun, L. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Med. Hypotheses; 2013. in press, 2013 May 14. pii: S0306-9877(13)00201-6. http://dx.doi.org/10.1016/j.mehy.2013.04.031.
147. Cai, X.; Xia, Z.; Zhang, C.; Luo, Y.; Gao, Y.; Fan, Z.; Liu, M.; Zhang, Y. Serum microRNAs levels in primary focal segmental glomerulosclerosis. Pediatr. Nephrol.; 2013. in press, 2013 Mar 6. http://dx.doi.org/10.1007/s00467- 013-2434-7.
148. Alvarez, M. L.; Distefano, J. K. Towards microRNA-based therapeutics for diabetic nephropathy. Diabetologia 56:444-456; 2013.
149. Elmen, J.; Lindow, M.; Schutz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H. F.; Berger, U.; Gullans, S.; Kearney, P.; Sarnow, P.; Straarup, E. M.; Kauppinen, S. LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899; 2008. (Pubitemid 351550859)
150. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689; 2005.
151. Putta, S.; Lanting, L.; Sun, G.; Lawson, G.; Kato, M.; Natarajan, R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23:458-469; 2012.
152. Snove Jr O.; Rossi, J. J. Expressing short hairpin RNAs in vivo. Nat. Methods 3:689-695; 2006. (Pubitemid 44275735)
153. Ebert, M. S.; Neilson, J. R.; Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4:721-726; 2007. (Pubitemid 47338166)